Matthew Sykes
Stock Analyst at Goldman Sachs
(3.83)
Main Sectors:
Top Industries:
38 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FTRE Fortrea Holdings | Maintains: Neutral | 7 5 | 9.45 | -47.09% | 4 | May 14, 2025 | |
CTKB Cytek Biosciences | Maintains: Sell | 4 3 | 3.97 | -24.43% | 9 | May 12, 2025 | |
TXG 10x Genomics | Maintains: Sell | 8 7 | 12.75 | -49.02% | 7 | May 12, 2025 | |
BRKR Bruker | Maintains: Neutral | 50 45 | 36.98 | 21.69% | 5 | May 8, 2025 | |
MYGN Myriad Genetics | Maintains: Buy | 14 8 | 8.06 | -0.74% | 12 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 48 | 31.07 | 54.49% | 10 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 17 | 15.95 | 6.58% | 1 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 160 | 193.89 | -17.48% | 4 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 10 | 9.1 | 9.89% | 8 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 140 125 | 94.09 | 32.85% | 2 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 14 | 14.29 | -2.03% | 6 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 240 | 214.72 | 11.77% | 5 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 26 | 15.19 | 71.17% | 10 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 190 170 | 177.39 | -4.17% | 4 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 49 56 | 62.84 | -10.88% | 13 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 80 | 118.26 | -32.35% | 11 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 1.49 | 0.67% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 160 190 | 167.35 | 13.53% | 13 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.88 | 98.86% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 5 | 3.09 | 37.54% | 10 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 37 | 36 | 2.78% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 56.72 | 14.6% | 12 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 206.62 | 21% | 2 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | n/a | n/a | 11 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 6.08 | 294.74% | 13 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1315.09 | -1.15% | 5 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 16.14 | -25.65% | 6 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 543.55 | 17.74% | 4 | Apr 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | 141.64 | 2.37% | 4 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | n/a | n/a | 5 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | n/a | n/a | 3 | Jul 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 4 | Apr 13, 2022 |